Distinguishing AIE from Celiac and Other Mimics
At a Glance
Autoimmune enteropathy cannot be confirmed by one antibody test alone. Doctors distinguish it from celiac disease, CVID, and medication-related enteropathy by combining symptoms, small-intestine biopsy findings, immune testing, medication review, and response to supervised changes.
Because autoimmune enteropathy (AIE) is exceptionally rare, the road to a diagnosis often involves ruling out more common conditions first. Many diseases can cause villous atrophy—where the tiny, nutrient-absorbing “fingers” of the small intestine flatten out—making AIE a “great masquerader” in the world of gastroenterology [1][2].
The Celiac Disease Comparison
The most common condition confused with AIE is celiac disease. In most cases, people with celiac disease improve on a gluten-free diet, but a small group has Refractory Celiac Disease (RCD), where the intestine does not heal despite strict dieting [3].
CRITICAL WARNING: Do not start or stop gluten, or undertake a gluten challenge, without a clinician and dietitian plan. Starting a gluten-free diet before testing can make celiac blood tests and biopsies unreliable.
Distinguishing AIE from RCD requires a close look at the tissue samples (biopsies) from the small intestine, and RCD requires confirmed celiac disease, verified diet adherence, and exclusion of other causes—not simply a failed diet trial:
- Cell Types: In AIE, doctors often see a significant loss or total absence of goblet cells (which make mucus) and Paneth cells (which protect against germs) [4]. These cells are usually preserved in celiac disease [5].
- Cell Death: AIE biopsies frequently show crypt apoptosis, a specific pattern of cell death in the “valleys” of the intestinal lining that is rare in celiac disease [4][6].
- Immune Markers: Doctors may use specialized tests like flow cytometry to look for “aberrant” or abnormal immune cells. Finding these abnormal cells strongly suggests a specific type of Refractory Celiac Disease (Type 2) rather than AIE [3].
Common Variable Immunodeficiency (CVID)
Common Variable Immunodeficiency (CVID) is a condition where the body does not produce enough antibodies to fight infections [5]. About 10% of people with CVID develop intestinal issues that look almost identical to AIE [1].
To tell them apart, an immunologist will look for:
- Blood Work: People with CVID have low levels of IgG antibodies, along with low IgA and/or IgM [5].
- Plasma Cells: Biopsies of the intestine in CVID patients typically show a lack of plasma cells, the cells responsible for making antibodies locally in the gut [5][6].
- Infection History: A history of frequent pneumonia, sinus infections, or ear infections, as well as impaired vaccine responses, often points toward CVID rather than AIE [5]. Before starting immunosuppression, infections like Giardia must also be explicitly ruled out.
The Role of Medication: Olmesartan
In adults, a blood pressure medication called Olmesartan is the best-established cause of an intestinal reaction that is virtually indistinguishable from AIE [7]. While reports with other angiotensin-receptor blockers (sartans) exist, they are less established.
Patients with this drug-induced reaction may even test positive for the same autoantibodies seen in AIE [7]. The primary way to distinguish the two is to safely stop the medication; if the symptoms resolve and the intestine heals, the cause was the drug rather than a primary autoimmune disorder [7][8]. Never stop a blood pressure medicine without the prescriber arranging an alternative. Other medications, such as mycophenolate, can also cause enteropathy.
Understanding the Antibody Tests
AIE is often associated with two specific markers in the blood: anti-enterocyte antibodies and anti-goblet-cell antibodies [2].
- Not a “Yes/No” Test: While these antibodies are helpful, they are not perfect, and assays are not universally standardized. In one study of adults with AIE, 15% tested negative for these antibodies [9]. In children, about 36% may test negative [10]. A negative result does not exclude AIE.
- Seronegative AIE: If you test negative but your biopsy and symptoms fit the pattern, you may have seronegative AIE. This is a clinical diagnosis of exclusion, made only after all mimics are eliminated [4][11].
- False Positives: These antibodies can sometimes appear in other conditions, including celiac disease or certain intestinal cancers, meaning they must be interpreted as part of the “whole picture” rather than on their own to confirm AIE [9].
Common questions in this guide
How can doctors distinguish autoimmune enteropathy from celiac disease?
Can a negative anti-enterocyte antibody test rule out autoimmune enteropathy?
What findings suggest CVID instead of autoimmune enteropathy?
Could olmesartan cause an intestinal reaction that looks like AIE?
Does failing to improve on a gluten-free diet prove that I have refractory celiac disease?
What do goblet cells, Paneth cells, and crypt apoptosis mean on a biopsy?
Get notified when new evidence is published on Primary autoimmune enteropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (11)
- 1
Advances and challenges in diagnosing and managing adult autoimmune enteropathy.
Christodoulidis G, Agko SE, Kouliou MN, et al.
World journal of gastroenterology 2025; (31(2)):99118 doi:10.3748/wjg.v31.i2.99118.
PMID: 39811507 - 2
Pediatric autoimmune disorders with gastrointestinal expressions: from bench to bedside.
Francalanci P, Cafferata B, Alaggio R, et al.
Pathologica 2022; (114(1)):32-39 doi:10.32074/1591-951X-339.
PMID: 34856606 - 3
AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
Green PHR, Paski S, Ko CW, Rubio-Tapia A
Gastroenterology 2022; (163(5)):1461-1469 doi:10.1053/j.gastro.2022.07.086.
PMID: 36137844 - 4
Clinical manifestations, diagnosis and long-term prognosis of adult autoimmune enteropathy: Experience from Peking Union Medical College Hospital.
Li MH, Ruan GC, Zhou WX, et al.
World journal of gastroenterology 2024; (30(19)):2523-2537 doi:10.3748/wjg.v30.i19.2523.
PMID: 38817655 - 5
Relieving the discrimination dilemma of adult autoimmune enteropathy and common variable immunodeficiency disease: two rare causes of chronic diarrhea and small intestinal villous atrophy.
Li M, Wang Q, Chen Y, et al.
Clinical rheumatology 2025; (44(8)):3353-3367 doi:10.1007/s10067-025-07523-8.
PMID: 40622608 - 6
Clinical manifestations and gastrointestinal pathology in 40 patients with autoimmune enteropathy.
Villanacci V, Lougaris V, Ravelli A, et al.
Clinical immunology (Orlando, Fla.) 2019; (207()):10-17 doi:10.1016/j.clim.2019.07.001.
PMID: 31279857 - 7
Gastrointestinal Disorder Associated with Olmesartan Mimics Autoimmune Enteropathy.
Scialom S, Malamut G, Meresse B, et al.
PloS one 2015; (10(6)):e0125024 doi:10.1371/journal.pone.0125024.
PMID: 26101883 - 8
Olmesartan-Associated Enteropathy: A Review of Clinical and Histologic Findings.
Choi EY, McKenna BJ
Archives of pathology & laboratory medicine 2015; (139(10)):1242-7 doi:10.5858/arpa.2015-0204-RA.
PMID: 26414468 - 9
Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center.
van Wanrooij RLJ, Neefjes-Borst EA, Bontkes HJ, et al.
Clinical and translational gastroenterology 2021; (12(8)):e00387 doi:10.14309/ctg.0000000000000387.
PMID: 34333499 - 10
Clinical characteristics and management of autoimmune enteropathy in children: case reports and literature review.
Jin M, Gong Y, Liu W, Zhong X
BMC pediatrics 2023; (23(1)):601 doi:10.1186/s12887-023-04435-x.
PMID: 38017413 - 11
Seronegative Adult Autoimmune Enteropathy in a Male Traveler.
McCabe P, Alli-Akintade L, Stondell J
ACG case reports journal 2017; (4()):e19 doi:10.14309/crj.2017.19.
PMID: 28184376
This page is for informational purposes only and does not constitute medical advice. Do not change your gluten intake or blood-pressure medicines without guidance from your healthcare provider.